The availability of antiretroviral therapy has dramatically reduced the risk of HIV mother-to-child transmission (MTCT). However, mothers infected with multidrug resistant HIV (MDR-HIV) are at increased risk of MTCT. We report the case of a pregnant patient infected with MDR-HIV in whom MTCT was avoided with enfuvirtide use in late pregnancy and elective caesarean section.
European Collaborative Study.Mother-to-child transmission in the era of highly active antiretroviral therapy.Clin Infect Dis2005; 40: 458–65.
2.
LalezaryJP, HenryK, O'HeamM; for the TORO 1 Study Group. Enfuvirtide, and HIV-1 fusion inhibitor, for drug-resistant HIV infection in north and south America.N Engl J Med2003; 348: 2175–85.
3.
LazzarinA, ClotetB, CooperD.for the TORO 2 Study Group. Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia.N Engl J Med2003; 348: 2186–95.
4.
ConnorEM, SperlingRS, GelberR.Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment.N Engl J Med1994; 331: 1173–80.
5.
RouziouxC, CostagiolaD, BurgardM.Estimated timing of mother-to-child human immunodeficiency virus type 1 transmission by use of a Markov model.Am J Epidemiol1995; 142: 1330–7.
6.
NielsenK, BoyerP, DillonM.Presence of human immunodeficiency virus (HIV) type 1 and HIV-1-specific antibodies in cervicovaginal secretions of infected mothers and in the gastric aspirates of their infants.J Infect Dis1996; 173: 1001–4.
7.
MeyohasMC, LacombeK, CarbonneB, Morand-JoubertL, GirardPM.Enfuvirtide prescription at the end of pregnancy to a multi-treated HIV-infected woman with virological breaktrough.AIDS2004; 18: 1966–8.
8.
CohanD, FeakinsC, WaraD.Perinatal transmission of multidrug-resistant HIV-1 despite viral suppression on an enfuvirtide-based treatment regimen.AIDS2005; 19: 989–90.
9.
Brennan BensonP, ParkianathanM, RiceP.Enfurvitide prevents vertical transmission of multidrug-resistant HIV-1 in pregnancy but does not cross the placenta.AIDS2006; 20: 297–9.
10.
WensingAMJ, BoucherCAB, van KasterenM, van DiikenPJ, GeelenSP, JuttmannJR.Prevention of mother-to-child transmission of multidrug resistant HIV-1 using maternal therapy with both enfuvirtide and tipranavir.AIDS2006; 20: 1465–7.
11.
VettoreMV, SchechterM, MeloMF, BoechatLJ, BarrosoPF.Genital HIV-1 viral load is correlated with blood plasma HIV-1 viral load in Brazilian women and is reduced by antiretroviral therapy.J Infect2006; 52: 290–3.
12.
GhosnJ, ChaixML, PeytavinG.Penetration of enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of HIV-1 infected men.AIDS2004; 18: 1958–61.
